Rebecca Bresnahan

Lower Lane, L9 7LJ
Liverpool, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Interventions to safely and effectively reduce (taper) use of opioids in chronic non-cancer pain: a systematic review.

Interventions to safely and effectively reduce (taper) use of opioids in chronic non-cancer pain: a systematic review.

Journal: Health technology assessment (Winchester, England)

Published: March 30, 2026

Cholera Toxin-Mediated Targeting of Botulinum Neurotoxin Activity to Pain-Associated Sensory Neurons.

Cholera Toxin-Mediated Targeting of Botulinum Neurotoxin Activity to Pain-Associated Sensory Neurons.

Journal: Toxins

Published: January 19, 2026

Reporting guidelines for protocols of randomised controlled trials of implantable neurostimulation devices: the SPIRIT-iNeurostim extension.

Reporting guidelines for protocols of randomised controlled trials of implantable neurostimulation devices: the SPIRIT-iNeurostim extension.

Journal: EClinicalMedicine

Published: July 02, 2024

Reporting guidelines for randomised controlled trial reports of implantable neurostimulation devices: the CONSORT-iNeurostim extension.

Reporting guidelines for randomised controlled trial reports of implantable neurostimulation devices: the CONSORT-iNeurostim extension.

Journal: EClinicalMedicine

Published: July 02, 2024

Biopsychosocial Approaches for the Management of Female Chronic Pelvic Pain: A Systematic Review.

Biopsychosocial Approaches for the Management of Female Chronic Pelvic Pain: A Systematic Review.

Journal: BJOG : an international journal of obstetrics and gynaecology

Published: May 07, 2024

Lamotrigine add-on therapy for drug-resistant focal epilepsy.

Lamotrigine add-on therapy for drug-resistant focal epilepsy.

Journal: The Cochrane database of systematic reviews

Published: December 11, 2023

Correction: Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15.

Correction: Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15.

Journal: PharmacoEconomics - open

Published: December 05, 2023

Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation.

Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation.

Journal: Health technology assessment (Winchester, England)

Published: October 15, 2023

Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15.

Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15.

Journal: PharmacoEconomics - open

Published: September 03, 2023

Estimated health effects from domestic use of gaseous fuels for cooking and heating in high-income, middle-income, and low-income countries: a systematic review and meta-analyses.

Estimated health effects from domestic use of gaseous fuels for cooking and heating in high-income, middle-income, and low-income countries: a systematic review and meta-analyses.

Journal: The Lancet. Respiratory medicine

Published: May 24, 2023

Perampanel add-on for drug-resistant focal epilepsy.

Perampanel add-on for drug-resistant focal epilepsy.

Journal: The Cochrane database of systematic reviews

Published: April 14, 2023

Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Journal: PharmacoEconomics - open

Published: March 08, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026